ARKG ETF — Holdings & Market Internals
A visuals-first look inside ARK Genomic Revolution ETF (ARKG): a weight-sized holdings treemap, sector concentration, and the breadth oscillators that reveal whether the fund's move is broad or narrow — built on the live 32-name holdings snapshot.
Historical breadth is computed against the current ARKG membership, so older values carry a degree of survivorship bias (constituents removed from the fund are excluded from past readings).
Holdings Treemap
Tile size = ETF weight, grouped by sector. Color by:
Sector Weights
Share of the fund by GICS-style sector.
Market Breadth Snapshot
How many constituents are participating in the trend. See the full internals →
Trend Alignment
Cap-weighted share of the fund by where price sits across its 20/50/200-day SMAs — 34% is in full alignment.
Valuation & Fundamentals
Sector multiples and dispersion across holdings (cap-weighted harmonic mean). Full valuation →
Valuation by Sector & Distribution
Fund P/E: 30.8 — cap-weighted harmonic mean. Green = cheaper than the fund.
By sector (cap-weighted)
Distribution across holdings
One-Month Leaders
Strongest constituents over the trailing month.
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | 2.09% | +101.18% | 64 |
| FRNM | Freenome, Inc. Common stock | 0.58% | +27.54% | 55 |
| SCTX | Scribe Therapeutics Inc. Common Stock | 0.64% | +26.48% | 53 |
| TXG | 10x Genomics, Inc. Class A Common Stock | 10.26% | +22.38% | 70 |
| PACB | Pacific Biosciences of California, Inc. | 0.74% | +19.47% | 51 |
| PSNL | Personalis, Inc. Common Stock | 5.86% | +13.96% | 54 |
One-Month Laggards
Weakest constituents — candidates for the opportunity scan.
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | 1.78% | -8.96% | 30 |
| BEAM | Beam Therapeutics Inc. Common Stock | 3.26% | -11.52% | 34 |
| QSI | Quantum-Si Incorporated Class A Common Stock | 0.27% | -15.20% | 41 |
| ABSI | Absci Corporation Common Stock | 4.63% | -15.55% | 41 |
| ALMR | Alamar Biosciences, Inc. Common Stock | 1.45% | -15.77% | 42 |
| BFLY | Butterfly Network, Inc. | 1.86% | -21.17% | 42 |
Holdings Explorer
Top 30 by weight — sort any column. View all 32 holdings →
| TXG | 10x Genomics, Inc. Class A Common Stock | Industrials | 10.26% | $69.89 | +2.24% | +22.38% | +137.74% | 70 | 100 | $8.2B |
| TWST | Twist Bioscience Corporation Common Stock | Health Care | 8.33% | $134.56 | +5.91% | +6.76% | +79.62% | 56 | 100 | $8.5B |
| TEM | Tempus AI, Inc. Class A Common Stock | Technology | 7.67% | $61.76 | +5.47% | +13.79% | +25.05% | 53 | 35 | $11.7B |
| CRSP | CRISPR Therapeutics AG | Health Care | 5.92% | $52.95 | +2.37% | -2.43% | +6.36% | 44 | 57 | $5.5B |
| PSNL | Personalis, Inc. Common Stock | Health Care | 5.86% | $16.22 | +0.49% | +13.96% | +72.02% | 54 | 99 | $1.8B |
| ABSI | Absci Corporation Common Stock | Health Care | 4.63% | $8.15 | -1.58% | -15.55% | +22.58% | 41 | 99 | $1.5B |
| GH | Guardant Health, Inc. Common Stock | Health Care | 4.43% | $167.26 | +6.62% | +1.19% | +26.05% | 57 | 99 | $21.9B |
| NTRA | Natera, Inc. Common Stock | Health Care | 4.28% | $342.63 | +4.00% | +7.59% | +52.78% | 67 | 97 | $47.2B |
| CDNA | CareDx, Inc. | Health Care | 4.00% | $52.56 | +4.34% | +10.18% | +122.57% | 68 | 99 | $2.6B |
| ILMN | Illumina Inc | Health Care | 3.96% | $207.92 | +0.86% | +7.32% | +24.05% | 51 | 97 | $32.2B |
| LLY | Eli Lilly & Co. | Health Care | 3.90% | $1136.51 | +2.01% | -8.08% | -2.29% | 42 | 92 | $1.03T |
| CMPS | COMPASS Pathways Plc American Depository Shares | Health Care | 3.47% | $14.60 | +1.32% | +2.39% | +26.66% | 57 | 99 | $1.8B |
| BEAM | Beam Therapeutics Inc. Common Stock | Health Care | 3.26% | $24.18 | +0.56% | -11.52% | -18.13% | 34 | 82 | $3.0B |
| NRIX | Nurix Therapeutics, Inc. Common stock | Health Care | 2.37% | $25.54 | +1.65% | -5.20% | +48.72% | 48 | 99 | $2.6B |
| RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | Health Care | 2.35% | $3.40 | +6.41% | +3.02% | +6.56% | 53 | 34 | $1.8B |
| ADPT | Adaptive Biotechnologies Corporation Common Stock | Health Care | 2.35% | $24.80 | +2.44% | -2.98% | +26.91% | 53 | 97 | $3.9B |
| WGS | GeneDx Holdings Corp. Class A Common Stock | Health Care | 2.30% | $89.53 | +5.46% | +8.67% | +44.23% | 65 | 32 | $2.6B |
| SDGR | Schrodinger, Inc. Common Stock | Health Care | 2.24% | $20.94 | +9.15% | +11.80% | +41.06% | 61 | 71 | $1.5B |
| VCYT | Veracyte, Inc. | Health Care | 2.12% | $40.86 | +0.83% | -8.89% | -13.26% | 39 | 87 | $3.6B |
| ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | Health Care | 2.09% | $15.20 | +3.80% | +101.18% | +119.37% | 64 | 38 | $476M |
| BFLY | Butterfly Network, Inc. | Health Care | 1.86% | $7.39 | +1.09% | -21.17% | +29.77% | 42 | 100 | $2.0B |
| NTLA | Intellia Therapeutics, Inc | Health Care | 1.82% | $11.97 | +1.36% | -1.94% | -3.42% | 43 | 61 | $1.8B |
| IONS | Ionis Pharmaceuticals, Inc. Common Stock | Health Care | 1.78% | $51.61 | -5.11% | -8.96% | -30.32% | 30 | 36 | $10.2B |
| ALMR | Alamar Biosciences, Inc. Common Stock | Industrials | 1.45% | $28.12 | +0.45% | -15.77% | +26.88% | 42 | 0 | $2.4B |
| PRME | Prime Medicine, Inc. Common Stock | Health Care | 1.38% | $3.25 | +1.92% | -1.55% | +12.77% | 43 | 37 | $673M |
| GENB | Generate Biomedicines, Inc. Common Stock | Health Care | 1.29% | $16.13 | +1.78% | +5.26% | +24.22% | 52 | 0 | $2.1B |
| CERS | Cerus Corp | Health Care | 1.00% | $2.55 | +3.21% | -6.59% | -2.11% | 44 | 97 | $524M |
| MASS | 908 Devices Inc. Common Stock | Industrials | 0.97% | $9.72 | +2.10% | -3.18% | +17.94% | 49 | 95 | $415M |
| PACB | Pacific Biosciences of California, Inc. | Industrials | 0.74% | $1.34 | +3.08% | +19.47% | +0.75% | 51 | 66 | $404M |
| SCTX | Scribe Therapeutics Inc. Common Stock | Health Care | 0.64% | $30.21 | -1.11% | +26.48% | -- | 53 | 0 | $598M |